Related Experiment Video
Updated: Mar 12, 2026

Chronic Stress Shifts Effort-Related Choice Behavior in a Y-Maze Barrier Task in Mice
Published on: August 13, 2020
A specific role for serotonin in overcoming effort cost
Florent Meyniel1,2,3, Guy M Goodwin4,5, Jf William Deakin6
1Motivation, Brain and Behavior team, Institut du Cerveau et de la Moelle épinière, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.
Serotonin, via escitalopram, reduces the perceived cost of effort, leading to increased action and higher rewards. This finding clarifies serotonin
Area of Science:
- Neuroscience
- Behavioral Economics
- Psychopharmacology
Background:
- Serotonin is crucial for behavioral regulation, influencing decisions involving costs like delay or punishment.
- Previous theories suggested serotonin modulates the impact of these costs on action selection.
Purpose of the Study:
- To investigate serotonin's role in regulating effort-based decision-making.
- To determine if selective serotonin reuptake inhibitors (SSRIs) affect the willingness to exert effort.
Main Methods:
- A double-blind, placebo-controlled study involving 58 healthy participants.
- Participants received either escitalopram (an SSRI) or placebo for 8 weeks.
- Behavioral task measuring the trade-off between physical effort (handgrip force) and monetary reward.
Main Results:
- Escitalopram treatment led to increased effort production and higher monetary payoffs compared to placebo.
- Computational analysis revealed a specific reduction in the subjective cost of effort.
- No significant change was observed in the valuation of monetary incentives.
Conclusions:
- Serotonin specifically modulates the cost of effort in action selection, extending its known regulatory roles.
- Findings provide a computational mechanism for the clinical effects of SSRIs in depression, potentially related to motivation.
- This research offers new insights into the neurobiological underpinnings of effort-based decision-making.
Related Concept Videos
Self-Discrepancy Theory
Self-Regulation
Antidepressant Drugs: MAOIs and Other Agents
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Coping Strategies: Emotion Focused

